黄类药物作为缺血性中风的有希望的治疗剂
Hongxin Shu1, Qiuye Liao1, Zhihao Chen1
1Department of Neurosurgery, the 2st affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China; Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, Jiangxi 330006, China; Jiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, Jiangxi 330006, China; Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi 330006, China.
黄类药物通过减少神经炎症和细胞死亡,对长期缺血性中风 (IS) 护理具有前途. 本综述探讨了它们的神经保护途径,推黄类药物作为IS患者潜在的临床治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物医学科学 生物医学科学
背景情况:
- 缺血性中风 (IS) 具有显著的死亡率和残疾,目前的治疗重点是短期护理.
- 对于IS的长期管理,急需新的治疗策略.
- 黄酸因其神经保护性质而成为长期IS护理的有希望的候选物.
研究的目的:
- 在缺血性中风的背景下,审查和总结黄类药物的神经保护途径.
- 为了阐明药理机制背后的抗神经炎症和抗丧作用的黄类药物.
- 进一步了解黄类药物的潜力,作为IS治疗的可行的临床选择.
主要方法:
- 关于黄类药物和缺血性中风研究的综合文献综述.
- 对药理学机制的分析,包括抗神经炎症和抗亡.
- 关于长期摄入黄类药物和IS结果的临床证据的综合.
主要成果:
- 在IS模型中,黄类药物在缓解神经炎症和预防细胞亡方面具有显著的潜力.
- 临床数据表明,持续的黄类药物消费改善了IS患者的长期结果.
- 既定的神经保护性药理动力学对于理解黄类药物的疗效至关重要.
结论:
- 黄胺为缺血性中风的长期治疗提供了一个有希望的治疗途径.
- 需要进一步研究黄类药物的特定神经保护途径.
- 黄类药物可能是改善IS患者长期康复的可行的临床候选者.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Cancer Prevention
Some...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...


